Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar?/? C57B...
Wedi'i Gadw mewn:
Prif Awduron: | , , , |
---|---|
Fformat: | Erthygl |
Iaith: | Saesneg |
Cyhoeddwyd: |
Philipps-Universität Marburg
2023
|
Pynciau: | |
Mynediad Ar-lein: | Testun PDF llawn |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Rhyngrwyd
Testun PDF llawnRhif Galw: |
urn:nbn:de:hebis:04-es2024-04459 |
---|---|
Dyddiad Cyhoeddi: |
2024-01-18 |
Ffynhonnell: |
Erstveröffentlichung: Oestereich, L.; Müller-Kräuter, H.; Pallasch, E.; Strecker, T. Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection. Viruses 2023, 15, 1436. https://doi.org/10.3390/v15071436 |
Downloads: |
19 (2024) |
Lizenz: |
https://creativecommons.org/licenses/by/4.0 |
URL mynediad: |
https://archiv.ub.uni-marburg.de/es/2024/0445 https://doi.org/10.3390/v15071436 |